FDA Seeks Public Input on AI Medical Devices That Can Change Their Answers

The FDA has released a discussion paper seeking public input on regulating generative AI in medical devices, focusing on how to address the variability and risks unique to AI-driven software over its product life cycle. The agency proposes a competency-based premarket evaluation inspired by doctor assessments and is inviting comments until October 19, signaling a move toward new regulatory approaches for AI in healthcare.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 19 sources have reported it between 18 Aug 2026 and 18 Sep 2026.